XSHG
600836
Market cap42mUSD
Jun 17, Last price
0.45CNY
Name
Shanghai Eliansy Industry Group Corp Ltd
Chart & Performance
P/E
—
P/S
0.58
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.44%
Rev. gr., 5y
-17.64%
Revenues
516m
+0.34%
Net income
0k
CFO
0k
-100.00%
Dividend
Jun 04, 20180.015 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shanghai Eliansy Industry Group Corporation Limited, together with its subsidiaries, engages in printing and medical services business in China and internationally. It offers green printing services; and trades in papers. The company also offers medical service training system; offers Chinese medicines; supplies pharmaceutical products; operates an Internet hospital specializing in chronic disease and cancer rehabilitation; operates a medical health industrial park; and real estate construction business, which include urban nursing home projects. It also invests in biomedicine, medical equipment, and health fields; information technology and artificial intelligence fields; and new materials, energy savings, and environment protection fields. The company was formerly known as Shanghai Jielong Industry Group Corporation Limited. Shanghai Eliansy Industry Group Corporation Limited is based in Shanghai, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||